Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Space Economy UCITS ETF 01.10.2026 FSPC.LN IE000ANMCD25   50,002.00 USD    980,871.73   19.617  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Rising Dividend Achievers UCITS ETF 01.10.2026 EDVY.LN IE000CPG9HG3   50,002.00 EUR   1,126,947.91   22.538  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 01.10.2026 UINC IE00BZBW4Z27 10,675,511.00 USD 416,378,504.08   39.003  ...
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3 Rotork plc

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3 Mitie Group plc

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-

Orano Med inaugure l’ATLab Valenciennes, premier site industriel européen dédié à la production d’alphathérapies ciblées au plomb-212

VALENCIENNES, France--(BUSINESS WIRE)--Regulatory News: Orano Med, filiale du groupe Orano et pionnière dans le domaine des alphathérapies ciblées en oncologie, a inauguré aujourd'hui l’ATLab (Alpha Therapy Laboratory), première installation pharmaceutique d'envergure industrielle en Europe dédiée à la production de radiothérapies internes vectorisées au plomb-212. La cérémonie s'est tenue à Onnaing, dans la métropole de Valenciennes, en présence de Claude Imauven, président du conseil d'admini...
-

Orano Med Inaugurates ATLab Valenciennes, Europe’s First Industrial Facility Dedicated to the Production of Lead-212-Based Targeted Alpha Therapies

VALENCIENNES, France--(BUSINESS WIRE)--Orano Med inaugurates ATLab Valenciennes, Europe’s first industrial facility dedicated to the production of lead-212-based targeted alpha therapies...
-

Hilgers PLLC Secures Major Defense Victory for Dometic in Earnout Dispute Over Igloo Acquisition

WILMINGTON, Del.--(BUSINESS WIRE)--The Delaware Court of Chancery has ruled in favor of Dometic Corp., finding that the company did not breach the agreement underlying its acquisition of cooler manufacturer Igloo, and declined to award ACON Igloo Holdings, LLC, any damages, let alone the $127 million sought by ACON at trial. The dispute arose from Dometic’s October 2021 acquisition of Igloo from private equity firm ACON Investments and events that occurred during the post-closing earnout period...
-

GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx introduces Easy Order at AAP 2026 to simplify genomic testing in everyday pediatric care...
-

Rivian Releases Q3 2026 Production and Delivery Figures and Sets Date for Third Quarter 2026 Financial Results

IRVINE, Calif.--(BUSINESS WIRE)--Rivian Automotive, Inc. (NASDAQ: RIVN) today announced production and delivery totals for the quarter ending September 30, 2026. The company produced 19,751 vehicles at its manufacturing facility in Normal, Illinois and delivered 19,248 vehicles during the same period. Production and delivery results for the quarter are in line with Rivian's outlook. The company is reaffirming its 2026 delivery range guidance of 65,000 - 70,000. The company also announced that o...